Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report

A patient with severe asthma on benralizumab therapy was admitted to the intensive care unit (ICU) for a coronavirus disease 2019 (COVID-19) infection. At the end of the 8 week benralizumab dosing interval, discussion arose as to whether benralizumab should be administered or if treatment should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroes, Johannes Anthon, Zielhuis, Sander Wilhelm, Bethlehem, Carina, Ten Brinke, Anneke, Van Roon, Eric Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251165/
https://www.ncbi.nlm.nih.gov/pubmed/33883206
http://dx.doi.org/10.1136/ejhpharm-2020-002660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251165/
https://www.ncbi.nlm.nih.gov/pubmed/33883206
http://dx.doi.org/10.1136/ejhpharm-2020-002660

Ejemplares similares